Breakingviews TV: Lilly’s meow

The drugmaker is following in Pfizer’s foostetps and floating its animal-health unit, which could be worth over $20 billion. Rob Cyran says it’s an opportunistic way to cash in on humans’ growing propensity to shower attention, and dollars, on their four-legged friends.

from Reuters Video: Breakingviews https://ift.tt/2uK3NHM